The MUR is usually conducted face to face in the pharmacy and allows an opportunity for the pharmacist to discuss the patient’s prescribed and non-prescribed medicines to increase their knowledge and understanding. It is a chance for any issues with taking the medicines, missing doses, side effects or patient concerns to be raised. The patient is given advice on medicines taking and with the patient’s permission any clinical issues are referred to their GPs.
22nd July 2019 announcement: MURs to be phased out:
In 2019/20 contractors can deliver a total of 250 MURs and in 2020/21 this will reduce to 100, with the service being decommissioned at the end of that year. All contractors can provide 250 MURs in total throughout 2019/20, but no more than 200 in the first half of the year.
Further information is available on the following LINK.
FAQs can be found HERE.
1st October 2019 update:
New targeting requirements apply to MURs conducted from 1st October 2019; these changes were agreed as part of the 5-year Community Pharmacy Contractual Framework agreement.
Seventy per cent of MURs conducted from 1st October 2019 to 31st March 2020 must be within the following two target groups:
- patients taking high-risk medicines; or
- patients recently discharged from hospital who had changes made to their medicines while they were in hospital.
From 1st October 2019, patients with respiratory disease and patients at risk of or diagnosed with cardiovascular disease and regularly being prescribed at least four medicines are no longer target groups for MURs.